ReviewCancers2025

Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies.

Nicolas Roussot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.